# Monopar Therapeutics: Form 8-K, filed Oct 30, 2024

- Company: [Monopar Therapeutics](/companies/mnpr.md) (CIK 1645469)
- Form: 8-K
- Filed: 2024-10-30
- Accepted by EDGAR: Oct 30, 2024, 16:05 ET
- Period: 2024-10-28
- Accession: 0001437749-24-032612
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1645469/000143774924032612/mnpr20241029_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1645469/000143774924032612/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1645469/000143774924032612/mnpr20241029_8k.htm

Filed Oct 30, 2024.
Source: SEC EDGAR, the filing index for accession 0001437749-24-032612. Last ingested by Listed: Nov 4, 2026, 20:49 ET. No prices; not investment advice.